The primary portion of the study is expected to be completed in 2026, with a completion date set for 2031. The trial is titled: 'PRIME: An Early Feasibility Study of a Robotically Implanted Brain-Computer Interface for the Control of External Devices.'
Neuralink is seeking subjects aged 22-75 with 'Severe quadriplegia (tetraplegia) due to spinal cord injury or amyotrophic lateral sclerosis (ALS) for at least one year without improvement,...'
The N1 implant is designed to record neural activity. Researchers will monitor for adverse events in the 72 months following the procedure, with the robot implanting the electrode thread.
[
add
]
[
|
|
...
]